NOVO INTEGRATED SCIENCES INC (NVOS) Stock Price, Forecast & Analysis
USA - NASDAQ:NVOS - US67011T3005 - Common Stock
NVOS Key Statistics, Chart & Performance
The current stock price of NVOS is 0.15 USD. In the past month the price decreased by -39.27%. In the past year, price decreased by -90.74%.
NVOS Latest News, Press Relases and Analysis
NVOS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.66 | 101.30B | ||
| CI | THE CIGNA GROUP | 9.43 | 71.54B | ||
| LH | LABCORP HOLDINGS INC | 16.95 | 22.29B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.35 | 21.12B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 112.65 | 20.35B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.19B | ||
| HIMS | HIMS & HERS HEALTH INC | 73.61 | 8.98B | ||
| DVA | DAVITA INC | 13.25 | 8.74B | ||
| CHE | CHEMED CORP | 20.25 | 6.49B | ||
| RDNT | RADNET INC | 206.58 | 6.04B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 33.25 | 6.01B | ||
| OPCH | OPTION CARE HEALTH INC | 19.23 | 4.65B |
Related stock screener links
About NVOS
Company Profile
Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 127 full-time employees. The company went IPO on 2005-07-12. The firm owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The firm operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.
Company Info
NOVO INTEGRATED SCIENCES INC
11120 Ne 2Nd Street, Suite 100
Bellevue WASHINGTON 98004 US
CEO: Robert Mattacchione
Employees: 179
Phone: 12066179797
NOVO INTEGRATED SCIENCES INC / NVOS FAQ
What does NOVO INTEGRATED SCIENCES INC do?
Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 127 full-time employees. The company went IPO on 2005-07-12. The firm owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The firm operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.
What is the current price of NVOS stock?
The current stock price of NVOS is 0.15 USD. The price decreased by -13.29% in the last trading session.
What is the dividend status of NOVO INTEGRATED SCIENCES INC?
NVOS does not pay a dividend.
How is the ChartMill rating for NOVO INTEGRATED SCIENCES INC?
NVOS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Is NOVO INTEGRATED SCIENCES INC (NVOS) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NVOS.
When does NOVO INTEGRATED SCIENCES INC (NVOS) report earnings?
NOVO INTEGRATED SCIENCES INC (NVOS) will report earnings on 2024-12-11, after the market close.
Who owns NOVO INTEGRATED SCIENCES INC?
You can find the ownership structure of NOVO INTEGRATED SCIENCES INC (NVOS) on the Ownership tab.
NVOS Technical Analysis
NVOS Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NVOS. Both the profitability and financial health of NVOS have multiple concerns.
NVOS Financial Highlights
Over the last trailing twelve months NVOS reported a non-GAAP Earnings per Share(EPS) of -1.38. The EPS increased by 84.52% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -68.87% | ||
| ROE | -244.36% | ||
| Debt/Equity | 0.16 |